Abstract Several lines of evidence link mutations and deletions in mitochondrial DNA (mtDNA) and its maternal inheritance to neurodegenerative diseases in the elderly. Age-related mutations of mtDNA modulate the tricarboxylic cycle enzyme activity, mitochondrial oxidative phosphorylation capacity and oxidative stress response. To investigate the functional relevance of specific mtDNA polymorphisms of inbred mouse strains in the proteostasis regulation of the brain, we established novel mitochondrial congenic mouse lines of Alzheimer's disease (AD). We crossed females from inbred strains (FVB/N, AKR/J, NOD/LtJ) with C57BL/6 males for at least ten generations to gain specific mitochondrial conplastic strains with pure C57BL/6 nuclear backgrounds. We show that specific mtDNA polymorphisms originating from the inbred strains differentially influence mitochondrial energy metabolism, ATP production and ATP-driven microglial activity, resulting in alterations of cerebral b-amyloid (Ab) accumulation. Our findings demonstrate that mtDNA-related increases in ATP levels and subsequently in microglial activity are directly linked to decreased Ab accumulation in vivo, implicating reduced mitochondrial function in microglia as a causative factor in the development of agerelated cerebral proteopathies such as AD.
Introduction mtDNA mutations become increasingly common throughout the body with advancing age [20] and are thought to be associated with several age-related neurodegenerative disorders [35] . However, there is little compelling evidence linking these mutations to specific pathological changes [6, 22] . Because engineering and integrating specific mutated mtDNA in mice is technically challenging, clinically relevant mouse models with pathological mtDNA mutations are rare [36] . Therefore, naturally occurring mtDNA polymorphisms in common inbred strains hold considerable promise for analyzing the pathogenic effects of polymorphic mtDNA. mtDNA variants interfere with cognitive abilities [30] , and differentially modulate mitochondrial oxidative phosphorylation (OXPHOS) and the generation of reactive oxygen species (ROS) [26] . The agerelated decline of respiratory chain function in mtDNAmutant mice was found to be more strongly affected by mtDNA point mutations than by deletions [11] . Numerous findings also implicate mitochondrial dysfunction and oxidative damage in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease (AD) [24] . For instance, depleting cells of endogenous mtDNA in vitro and repopulating them with mitochondria from AD patients resulted in respiratory chain deficiency and b-amyloid (Ab) accumulation [18, 33] . Sequencing of mtDNA from the blood or brain tissue of AD patients however yielded contradictory results [12, 34] . Hence, the hypothesized connection between specific mtDNA polymorphisms and defects in protein maintenance (protein homeostasis or proteostasis), specifically the cerebral accumulation of Ab, remains uncertain [9, 10] .
Materials and methods

Animal models and generation of congenic mouse lines
(1) APP-transgenic mice [29] (C57BL/6 gDNA and mtDNA background) were obtained from R. Radde and M. Jucker (University of Tübingen, Hertie Institute for Clinical Brain Research, Tübingen, Germany) and further maintained with C57BL/6 females for more than six generations (APP-B6). C57BL/6 female mice (B6) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). (2) APP-FVB mice were generated by crossing APP-transgenic mice to FVB/N females for more than ten generations. FVB/N female mice were purchased from the Jackson Laboratory. (3) Mouse inbred strains (FVB/N, AKR/J, NOD/LtJ) used to generate mtDNA conplastic strains were purchased from Jackson Laboratory. The mtDNA of each strain had been sequenced previously [38] . C57BL/6 (B6) was chosen as the gDNA and mtDNA reference strain because the APP-transgenic mouse model on the same background is well characterized [29, 31] . Based on the exclusive inheritance of maternal mtDNA [1] , we mated female mice manifesting the desired mtDNA variants with male B6 mice for more than ten generations to eliminate the nuclear DNA of the inbred strains AKR/J, FVB/N, and NOD/LtJ, respectively. APP-B6 males (Sect. 1 above) were then crossed to mtDNA strains to produce APPxmt AKR , APPxmt FVB and APPxmt NOD mice, respectively. (4) Uncoupling protein 2-knockout mice (Ucp2 0/0 , C57BL/6 gDNA and mtDNA background) were provided by Bruno Miroux. APP-B6 mice were crossed to Ucp2 0/0 mice to produce APP ?/0 xUCP2 0/0 mice. All mice were housed in a climate-controlled environment on a 12 h light/dark cycle with free access to rodent food (SNIFF, Germany) and water. All procedures were conducted in accordance with animal protocols approved by the University of Rostock and according to the state law of the government of Mecklenburg-Western Pomerania.
Tissue preparation
Mice were killed by cervical dislocation and transcardially perfused with PBS. The brain was removed, and one hemisphere was fixed in buffered, 4 % paraformaldehyde (PFA) for paraffin-embedding and immunohistochemistry, while the other hemisphere was snap-frozen in liquid nitrogen and stored at -80°C for biochemical analysis.
Enzyme-linked immunosorbent assay (ELISA)
ELISA kits (TK42HS-high sensitivity from The Genetics Company, Schlieren, Switzerland) were used for the quantification of Ab42 in whole brain hemispheres from which the cerebellum and brain stem had been removed at the level of the midbrain. Hemispheres were homogenized using PreCellys24 (12 s, 6,500 rpm). After addition of carbonate buffer (pH 8.0), homogenates were mixed using PreCellys (5 s, 5,000 rpm) and centrifuged for 90 min (4°C) at 24,000g to separate insoluble from soluble Ab species. The resulting supernatant (buffer-soluble fraction) was mixed with 8 M guanidine hydrochloride at a ratio of 1:1.6. To extract aggregated Ab species, the pellet was dissolved in 8 volumes of 5 M guanidine hydrochloride, shaken at room temperature for 3 h and centrifuged at 24,000g for 20 min at 4°C. The resulting supernatant represents the guanidine-soluble fraction. Protein contents of all samples were measured in triplicate using a Nanodrop1000 (Thermo Fisher Scientific, USA). ELISAs were performed according to the manufacturer's instructions using appropriate dilutions.
TCA and OXPHOS activity measurements in isolated mitochondria
Mitochondria from freshly prepared brain hemispheres were isolated as described elsewhere [38] . The mitochondria were adjusted to the same protein concentration as determined by BCA assay (Pierce, a division of Thermo Fisher Scientific, USA). The different enzymatic activities were assessed using the PARADIGM spectrophotometer (Beckman Coulter, USA). Pyruvate DH activity was measured using a PDH enzyme activity microplate assay kit (MitoScience, USA). Malate DH activity was measured by monitoring the absorbance at 340 nm in a reaction mixture containing 50 mM potassium phosphate buffer (pH 7.4), 0.4 mM NADH, 2 mM oxaloacetate and 10 lM rotenone. Complex I, III and ATPase activities were measured as described elsewhere [2, 38] . The ATPase activity represents complex V activity. Complex II and IV activities were measured using the respective enzyme activity microplate assay kits (MitoScience, USA).
Assessment of ATP and H 2 O 2 levels ATP and H 2 O 2 levels were measured in freshly prepared total brain homogenates. Assays were performed with either a luminescence (Infinite200Pro, Tecan, Switzerland) or spectrophotometric plate reader (PARADIGM, Beckman Coulter, USA). Tissue ATP levels were determined by a luciferin/luciferase ATP Bioluminescent Assay kit (Sigma-Aldrich, Germany). The Amplex Red hydrogen peroxide assay kit (Invitrogen, USA) was used to detect H 2 O 2 release. Sample preparation and assay procedures were performed according to the manufacturers' protocols. Due to the high activities of ATPases in fresh samples, tissue was immediately snap frozen in liquid nitrogen. All steps for sample preparation were carried out at 4°C in order to avoid the recovery of ATPase activity and subsequently degradation of ATP in the tissue.
Catalase and b-secretase activity measurements Enzyme activities were measured in total brain homogenates. The different enzymatic activities were assessed using the PARADIGM spectrophotometer (Beckman Coulter, USA). Catalase activity was measured by using an OxiSelect catalase activity assay kit (Cell Biolabs, USA). The activity of b-secretase was determined with a b-secretase activity assay kit (BioVision, USA). Sample preparation and assay procedures were performed according to the manufacturers' protocols.
Western blots
For Western blotting, tissue homogenates were prepared as described by Lesné et al. [23] . Total protein concentrations of the extracts were determined using a BCA assay (Pierce, division of Thermo Fisher Scientific, USA). After electrophoresis of 10 lg total protein per lane, proteins were blotted onto PVDF membranes. After blocking in 5 % dry milk in TBST buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.1 % Tween20) for 1 h at room temperature, blots were probed for ADAM10 (1:1,000, Calbiochem, USA), BACE1 (1:1,000, Abcam, UK), IDE (1:500, Abcam, UK), ApoE (1:2,000, Abcam, UK), ABCA1 (1:1,000, Novus Biologicals, USA), total OXPHOS antibody cocktail (1:1,000, MitoSciences, USA) or b-actin (1:40,000, Sigma-Aldrich, Germany) overnight at 4°C. As detection antibodies, anti-mouse-HRP and anti-rabbit-HRP, respectively, were used. The Amersham ECL Plus Detection kit (GE Healthcare, UK) and a Roper CoolSnap HQ 2 Camera (Roper, Germany) were used for visualization.
Immunohistochemistry
Brain hemispheres were post-fixed for at least 24 h in buffered, 4 % paraformaldehyde. Paraffin-embedded, 4-lmthick coronal sections were stained using a BondMax TM (Leica Microsystems GmbH, Germany) automated immunostaining system. Sections were pretreated with 98 % formic acid for 5 min and immunostained for Ab using the anti-human Ab clone 6F3D (1:200, 30 min, DAKO, Germany) and the Bond TM Polymer Refine Detection kit (Leica Microsystems GmbH, Germany). For double-stained slides, microglia were subsequently immunostained on the same sections using anti-Iba1 (1:1,000, 30 min, Wako GmbH, Germany) and the Bond TM Polymer AP-Red Detection kit (Leica Microsystems GmbH, Germany) [31] . Whole tissue sections were fully digitized at a resolution of 230 nm using Mirax Desk/Midi slide scanners (Zeiss, Germany) and then analyzed semi-automatically using the AxioVision software package (Zeiss Microimaging GmbH, Germany) as previously described in [31] .
Primary microglia preparation and Ab-phagocytosis assays Highly purified primary microglial cultures were prepared as described by Horvath et al. [15] with slight modifications. In brief, cerebral cortices of 2-to 3-day-old mice were minced and digested with 19 Trypsin/EDTA for 15 min at 37°C. Pelleted tissue was triturated several times on ice in Dulbecco's modified Eagle's medium supplemented with 10 % FBS, 1 % GlutaMax, 1 % penicillin/streptomycin and 2,000 units of DNase. Supernatant containing glial cells was collected, triturated again until the tissue clumps disappeared and finally centrifuged at 340g for 15 min. The cell pellet was re-suspended in media and plated at 2 9 10 6 cells per 75 cm 2 flask. Cultures were maintained at 37°C and 5 % CO 2 . Media were changed every 3-4 days. After 20 days in culture, the flask was shaken at 250 rpm for 45 min, and the primary microgliaenriched supernatant was removed and centrifuged at 340g for 15 min. To assess the phagocytosis of Ab, the cell pellet was resuspended in media and plated at 30,000 primary microglia per well onto a 96-well plate. Peptide phagocytosis was quantified by measuring the uptake of FITC-labelled Ab42 (rPeptide, USA). Ab aggregates (500 nM) were incubated with the microglia for 6 h. Then the medium was removed and the remaining cells were washed twice with PBS and trypsinized. The cells were centrifuged at 340g for 15 min and resuspended in PBS. Intracellular fluorescence (excitation 485 nm and emission 535 nm) was measured with the PARADIGM spectrophotometer (Beckman Coulter, USA).
Immunofluorescence
Primary microglia were seeded at 200,000 cells per 6-well plate onto poly-D-lysine-coated cover slips. After 24 h incubation with 500 nM FITC-labeled Ab42, cells were fixed with 2 % paraformaldehyde for 5 min and then icecold methanol for an additional 5 min. Primary microglia were immunolabelled using an antibody against Iba1 (1:1,000, Wako GmbH, Germany) for 1 h. Detection was performed with goat anti-rabbit Cy3 (1:1,000, Dianova, Germany). Cells were counterstained and mounted using VECTASHIELD with DAPI (Biozol, Germany). Visualization was achieved with a Zeiss Laser Scanning Microscope (LSM700, Zeiss, Germany).
Results
Inbred AD mouse strains show distinct differences in Ab load
Support for a link between DNA polymorphisms and altered protein homeostasis comes from the initial evaluation of the influence of the C57BL/6J (B6) and FVB/N murine strain backgrounds on cerebral Ab accumulation in APP-transgenic mice. B6 and FVB/N mice differ substantially in nuclear and mitochondrial DNA. ELISA quantifications revealed significantly lower Ab levels in APP-FVB mice compared to APP-B6 mice at 200 days of age (Fig. 1 ). This indicates that nuclear and/or mitochondrial DNA variations may cause these differences while expressing the identical APP transgenes.
Conplastic mice show distinct biochemical differences
To determine whether the observed differences in Ab levels are indeed caused by mtDNA differences between B6 and FVB/N, we established new mtDNA congenic AD mouse lines by using common inbred strains (FVB/N, AKR/J, NOD/LtJ) with naturally occurring mtDNA polymorphisms leading to coding and non-coding nucleotide exchanges ( Table 1) . As mitochondria are inherited maternally, we backcrossed female mice of these strains for at least ten generations with B6 males to gain solely mitochondrial differences on an otherwise pure B6 background (B6xmt AKR/J , B6xmt FVB/N , and B6xmt NOD/LtJ ). The offsprings after the tenth generation were regarded as congenic/conplastic strains that carried the nuclear genome of the recipient strain and the mitochondrial genome from the donor strains. The resulting congenic mtDNA mice were then crossed to APP-B6 males to evaluate intracere- Arg in all three mtDNA congenic mouse strains previously described to alter not only hearing ability in mice, but also to differentially affect ROS production in transmitochondrial cybrids [17, 26] ; (2) a coding substitution in the ATP synthase subunit 8 (Atp8) gene in the mt FVB DNA, altering mitochondrial function [38] ; (3) a coding substitution in the cytochrome c oxidase subunit 3 (Cox3) gene in mt NOD mice, leading to decreased complex IV activity ( Supplementary Fig. 2) ; (4) a non- coding substitution in the NADH dehydrogenase subunit 3 (Nd3) gene in all three mtDNA congenic mouse strains. The relevance of non-coding single nucleotide exchanges in the NADH dehydrogenase gene is as yet unknown; however, transcriptional regulation of NADH dehydrogenase subunits has been discussed in the context of proteostasis defects [5] .
To evaluate the impact that the mtDNA variants have on cellular metabolism, we first analyzed the enzymatic activities of the components of the respiratory chain complex, the tricarboxylic acid cycle (TCA) and the resulting cellular ATP levels in the brain. In all mtDNA mouse strains, we found significant differences in TCA enzymes and OXPHOS complex activities ( Supplementary Figs. 1,  2 ) that ultimately resulted in significantly increased ATP levels in mt NOD mice (?75 %), and non-significantly in mt AKR mice (?35 %) and in mt FVB mice (?52 %, Fig. 3a ). Because ROS production differs in relation to murine mitochondrial DNA haplotypes [26] , we then measured hydrogen peroxide (H 2 O 2 ) levels and catalase activity in the conplastic AD mice. H 2 O 2 levels were reduced only in the mt FVB strain (-48 %), whereas catalase activity was unchanged in all mtDNA strains and B6 controls (Supplementary Fig. 3) . Overall these results demonstrate that single nucleotide differences in the mtDNA can cause substantial metabolic changes.
Conplastic mice exhibit differences in Ab load
To reveal which impact these metabolic changes have on cerebral proteostasis, we quantified Ab in the conplastic AD strains. Immunohistochemical analysis showed that Ab-immunoreactive senile plaques were reduced both in size and number in all mtDNA conplastic strains compared to the APP-B6 controls (Fig. 2a-g ). Quantification of cortical plaques in progressively older age groups of mice showed that mt NOD mice had a lower areal density of plaques evident as early as at 75 days of age, whereas plaque load in the other groups (mt AKR , mt FVB ) was similar to controls until 175 days of age. At 200 days of age, plaque load was significantly lower in all mtDNA-variant mice (Fig. 2h) . These findings were confirmed by ELISA measurements in which Ab levels were significantly lower in the mtDNA variant mice (-59 % mt AKR , -65 % mt FVB , -82 % mt NOD ) (Fig. 2i) . Again, lower Ab levels were apparent in the mt NOD mice as early as 75 days of age ( Fig. 2i and Supplementary Fig. 4 ). To exclude that the differences in Ab deposition are due to alterations in APP processing pathways, we measured the levels of several proteins/proteases involved in the production, degradation or trafficking of Ab. The expression of a-secretase (ADAM10), b-secretase (BACE1), ABCA1, ApoE or IDE did not differ as a function of mitochondrial status. In addition, b-secretase activity did not differ significantly among the mouse strains as determined at 200 days of age ( Supplementary Fig. 5 ). These results reveal that other mechanisms are likely involved in the changed Ab proteostasis.
Microglia function is regulated by conplastic mitochondria
Activated microglial cells rely strongly on mitochondrial function; they are a prominent feature of Ab plaques and are known to be involved in the phagocytosis of Ab [14, 28] . Thus, we were interested whether the mtDNA polymorphisms result in variations of the cerebral proteostasis due to changes in microglial activity. We found severe microgliosis in mtDNA-variant mice at 200 days of age, most prominently in the mt NOD mice (Fig. 3c-f ). All conplastic strains exhibited significantly greater numbers of Ab plaques that were heavily covered ([50 %) by microglia at day 100 (?128 % mt AKR , ?153 % mt FVB and ?186 % mt NOD ), whereas only mt NOD mice maintained a significantly elevated microglial response at 200 days of age (?93 %, the endpoint of our analysis) (Fig. 3b) . To assess the potential association between microglial mtDNA polymorphisms and the number and size of Ab plaques, we studied the phagocytosis of Ab by microglia in vitro. Immunofluorescence analysis of Iba1-positive microglia isolated from mtDNA mice and B6 controls incubated with fluorescein-coupled Ab42 revealed an intravesicular localization of Ab aggregates (Fig. 3g) . Quantification of Ab phagocytosis in mt NOD mice, which show the lowest cerebral Ab load, demonstrated significantly higher uptake levels in microglia compared to B6 controls (Fig. 3h) . These findings suggest that ATP-triggered microglial activity plays an important role in Ab homeostasis.
High ATP levels reduce Ab load
The most striking effects in Ab reduction are found in mt NOD mice compared to mt AKR , mt FVB and B6 control NOD strain, the cortical area occupied by plaques is significantly less at 75 days of age, and by approximately 175 days of age, it is reduced in all congenic mtDNA mice. i The histopathological findings are confirmed by Ab42-ELISA. Data are means ± SEM (n C 5 per group), *p \ 0.05 mice. Interestingly, these mice also exhibit the highest ATP levels. It is known that release of ATP triggers microglial response, and this might therefore explain amplified microglial activity toward aggregated Ab [7, 8] . To support the ATP dependency of this phenomenon, we additionally established an mtDNA-independent AD model lacking the nuclear genome-encoded ATP-bypass enzyme uncoupling protein 2 (APP 9 UCP 0/0 ). Higher levels of ATP have been observed in various cells types of UCP2-deficient mice [19, 39] . As expected, the APP 9 UCP 0/0 mice also exhibit much higher ATP levels. Most importantly, these mice have significantly lower Ab levels in the brain (Fig. 4) , which suggests an inverse correlation of increased ATP and reduced Ab levels.
Discussion
In this study, we analyzed conplastic mouse models with identical nuclear but divergent mitochondrial genomes, and thereby provide the first in vivo evidence that specific mtDNA variants in common inbred mouse strains can substantially influence the cerebral proteostasis network, indicating a potential role of mtDNA mutations in the ontogeny of neurodegenerative diseases. In particular, we found distinct biochemical alterations resulting in higher ATP levels, lower plaque number and size, lower Ab levels and a pronounced microglial response to Ab. Energetic differences influence the phagocytic activity of microglia toward Ab, which is necessary for plaque removal; hence, the microglial activation state may be an important regulator of the progression of cerebral Ab amyloidosis. In line with this, ablation of the majority of parenchymal microglia in one study suggested that amyloid formation and maintenance are not dependent on the presence of microglia in APP-transgenic mice on a B6 genomic background that miss the energetic phagocytic microglial activation [13] . Senescence leads to the accumulation of random mitochondrial changes in cells and tissues and to an age-related switch in microglial function from phagocytic to more cytotoxic in vivo [16, 31] . Increased heteroplasmy of random mitochondrial polymorphisms accumulating with age could engender gross functional and regulational deficiencies in specific mitochondrial pathways, thus contributing to functional changes of ATPconsuming mechanisms, e.g., Ab export from the brain [3, 21, 25] , fostering sporadic forms of AD. Consequently, no specific, inherited mtDNA variations have yet been discovered as linked to AD, although several studies have sought to ascertain the presence of mtDNA polymorphisms and maternal inheritance in AD patients [4, 5, 27, 34, 37] . The FVB/N and AKR/J strains have a double and the NOD/ LtJ a treble A-repeat. Mutations in mtRNA Arg result in an altered conformation and OXPHOS deficiencies in patients [32] . Moreover, alterations of regulatory mechanisms, such as a reduction in the amount of transcripts of NADH dehydrogenase subunits, have been proposed as potential risk factors for AD [5] .
Together, ATP level alterations due to functional variations in OXPHOS and/or TCA cycle variations that are caused by accumulating mtDNA mutations lead to beneficial or detrimental effects for the brain's proteostasis 0/0 mice show a significant 52 % reduction in Ab42. d The cortical area occupied by amyloid plaques is significantly reduced in the APP-UCP 0/0 strain starting already at 100 days of age. Data are presented as means ± SEM (n C 5 per group), *p \ 0.05 networks and may thus play an important role in the development or even prevention of age-related neurodegenerative diseases.
